A system establishment compatibility profiles for artificial oxygen carriers and other substances

Area of Science:

• Biomedical Engineering
• Toxicology
• Immunology

Background:

• Clinical application of artificial oxygen carriers requires rigorous toxicological and immunological assessment.
• Species-specific differences in animal models complicate the evaluation of inflammatory parameters.
• An in vitro system using human components is needed to accurately assess compound compatibility.

Purpose of the Study:

• To develop and validate an in vitro system for assessing the toxicological and immunological compatibility of artificial oxygen carriers.
• To compare the compatibility profiles of lecithin-based and Pluronic-based perfluorodecalin (PFD) emulsions using the developed in vitro system.

Main Methods:

• The in vitro system assesses hemolysis, complement activation (C3a), cytokine production, cell proliferation, leukocyte toxicity, and phagocytosis.
• Human peripheral blood leukocytes, endothelial (ECV 304), and monocytic (MonoMac6) cell lines were utilized.
• Perfluorodecalin (PFD) emulsions based on lecithin and Pluronic were tested.

Main Results:

• Pluronic-based PFD emulsions exhibited minimal toxicity to human leukocytes, with no significant hemolysis or inhibition of cell proliferation.
• Lecithin-based PFD emulsions demonstrated substantial cytotoxicity to monocytes (60-100%) and granulocytes (10-20%).
• Lecithin-based PFD emulsions suppressed endotoxin-induced cytokine production (>98%) and cell proliferation (>95%) in relevant cell lines.

Conclusions:

• The developed in vitro system provides a reliable method for evaluating the compatibility of artificial oxygen carriers using human components.
• Pluronic-based PFD emulsions present a safer alternative to lecithin-based emulsions due to their superior biocompatibility with human leukocytes.
• Further research into Pluronic-based PFD emulsions is warranted for their potential clinical application as artificial oxygen carriers.